Avron Hospitals

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes4 trials
• Obesity3 trials
• Obstructive sleep apnoea2 trials
• Fatty liver disease (MASLD/MASH)1 trial
• Osteoarthritis1 trial
• Rheumatoid arthritis1 trial

Phase

• Phase 35 trials
• Phase 21 trial

Status

• Completed3 trials
• Not yet recruiting2 trials
• Recruiting1 trial

Lead sponsor

• Eli Lilly and Company6 trials

Running trials

• Not yet recruiting

  A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes

  NCT07881432· Phase 3· Eli Lilly and Company· Source

  Contact: Tiven Marwah (principal investigator)

• Recruiting

  A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes

  NCT07668336· Phase 3· Eli Lilly and Company· Source

  Contact: Tiven Marwah (principal investigator)

• Recruiting

  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  NCT07165028· Phase 3· Eli Lilly and Company· Source

  Contact: Tanmay Vyas (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Type 2 diabetes2 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Obesity1 recruiting

Closed trials

• Completed

  A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight

  NCT05929079· Phase 3· Eli Lilly and Company· Source

• Completed

  A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight

  NCT05929066· Phase 3· Eli Lilly and Company· Source

• Completed

  An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis

  NCT05848258· Phase 2· Eli Lilly and Company· Source